banner
Glycine max lectin (SBA), Soybean, Unconjugate
Inquiry

Cat. No.: XLC-28-01Q

Glycine max lectin (SBA), Soybean, Unconjugate

Synonym: SBA; Soybean-agglutinin

img
Product Size
10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
Glycine max lectin (SBA) specially binds to Galactose and N-Acetylgalactosamine. Inhibiting or Eluting Sugar: N-Acetylgalactosamine. This product can be used in glycobiology, immunochemistry, immunofluorescence, western blot, enzyme-linked immunosorbent assay and mitogenic stimulation.
Biological Source
Soybean
Conjugate
Unconjugate
Carbonhydrate Specificity
Galactose; N-Acetylgalactosamine
Inhibiting or Eluting Sugar
N-Acetylgalactosamine
Blood Group Specificity
Non-specific
Divalent Ions
Ca++, Mn++
Form
Solid
Buffer
0.01 M HEPES (pH 8.5) with 0.1 mM CaCl2
Preservative
0.08% sodium azide
Applications
Glycobiology, Immunochemistry, Immunofluorescence, Western blot, Enzyme-linked immunosorbent assay, Mitogenic stimulation
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.
0